Cargando…

The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations

Cystic fibrosis (CF) is characterized by defective mucociliary clearance and chronic airway infection by a complex microbiota. Infection, persistent inflammation and periodic episodes of acute pulmonary exacerbation contribute to an irreversible decline in CF lung function. While the factors leading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fodor, Anthony A., Klem, Erich R., Gilpin, Deirdre F., Elborn, J. Stuart, Boucher, Richard C., Tunney, Michael M., Wolfgang, Matthew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458854/ https://www.ncbi.nlm.nih.gov/pubmed/23049765 http://dx.doi.org/10.1371/journal.pone.0045001

Ejemplares similares

Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study
por: O'Neill, Katherine, et al.
Publicado: (2017)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?
por: Lee, Andrew J., et al.
Publicado: (2020)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs
por: Einarsson, Gisli G., et al.
Publicado: (2022)

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
por: Carmody, Lisa A, et al.
Publicado: (2015)

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2015)

P177 Characterisation of pathogens causing lung infection in people with cystic fibrosis by surface-enhanced Raman spectroscopy (SERS)
por: Allen, D., et al.
Publicado: (2019)

Lung function and microbiota diversity in cystic fibrosis
por: Cuthbertson, Leah, et al.
Publicado: (2020)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions
por: McCaughey, Gerard, et al.
Publicado: (2013)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
por: Vallières, Emilie, et al.
Publicado: (2016)

Longitudinal development of the airway microbiota in infants with cystic fibrosis
por: Ahmed, Bushra, et al.
Publicado: (2019)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Protein biomarkers in cystic fibrosis research: where next?
por: Pattison, Sally H, et al.
Publicado: (2010)

Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
por: Fluit, Ad C., et al.
Publicado: (2022)

Draft Genome Sequence of Haemophilus haemolyticus Strain 16/010 O, Isolated from a Sputum Sample from a Cystic Fibrosis Patient
por: Fluit, Ad C., et al.
Publicado: (2019)

Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care (Commentary)()
por: Elborn, J Stuart
Publicado: (2021)

Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway during Exacerbation
por: Twomey, Kate B., et al.
Publicado: (2013)

Polarized Signaling via Purinoceptors in Normal and Cystic Fibrosis Airway Epithelia
por: Paradiso, Anthony M., et al.
Publicado: (2001)

Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens
por: Gilpin, Deirdre F., et al.
Publicado: (2019)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
por: Chalhoub, Hussein, et al.
Publicado: (2017)

Organisms isolated from adults with Cystic Fibrosis
por: McManus, Terence E, et al.
Publicado: (2004)

Soluble Mediators, Not Cilia, Determine Airway Surface Liquid Volume in Normal and Cystic Fibrosis Superficial Airway Epithelia
por: Tarran, Robert, et al.
Publicado: (2006)

Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
por: Cox, Michael J., et al.
Publicado: (2010)

Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients
por: Boutin, Sébastien, et al.
Publicado: (2017)

Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
por: Caverly, Lindsay J., et al.
Publicado: (2021)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD
por: Dicker, Alison J, et al.
Publicado: (2018)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Reduced Bacterial Colony Count of Anaerobic Bacteria Is Associated with a Worsening in Lung Clearance Index and Inflammation in Cystic Fibrosis
por: O’Neill, Katherine, et al.
Publicado: (2015)

Therapeutic interventions alter ecological interactions among cystic fibrosis airway microbiota
por: Ho, Pok-Man, et al.
Publicado: (2023)

A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis
por: Fouhy, F., et al.
Publicado: (2017)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation
por: Nguyen, Linh Do Ngoc, et al.
Publicado: (2016)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_92vdg28kj0j4i2bbmrr0hpbnu5